Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 2.8K |
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity | Proceedings of the National Academy of Sciences of the United States of America | 2013 | 2.5K |
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics | Nature Reviews Gastroenterology and Hepatology | 2017 | 2K |
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Gut | 2016 | 938 |
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice | Nature Medicine | 2017 | 896 |
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study | Nature Medicine | 2019 | 650 |
Human gut microbiome: hopes, threats and promises | Gut | 2018 | 599 |
Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling | Cell Metabolism | 2015 | 562 |
Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice | Scientific Reports | 2015 | 464 |
Next-Generation Beneficial Microbes: The Case of | Frontiers in Microbiology | 2017 | 459 |
Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity | Proceedings of the National Academy of Sciences of the United States of America | 2014 | 455 |
Human Intestinal Barrier Function in Health and Disease | Clinical and Translational Gastroenterology | 2016 | 396 |
Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity | ISME Journal | 2014 | 376 |
Diabetes, obesity and gut microbiota | Bailliere's Best Practice and Research in Clinical Gastroenterology | 2013 | 360 |
Multiparametric imaging of biological systems by force-distance curve-based AFM | Nature Methods | 2013 | 317 |
Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate | Thrombosis and Haemostasis | 2012 | 277 |
Gut microbiome and liver diseases | Gut | 2016 | 252 |
Prebiotics: why definitions matter | Current Opinion in Biotechnology | 2016 | 245 |
Homeostasis of the gut barrier and potential biomarkers | American Journal of Physiology - Renal Physiology | 2017 | 240 |
Gut microbiota, enteroendocrine functions and metabolism | Current Opinion in Pharmacology | 2013 | 238 |
Microbial modulation of energy availability in the colon regulates intestinal transit | Cell Host and Microbe | 2013 | 232 |
Can probiotics modulate human disease by impacting intestinal barrier function? | British Journal of Nutrition | 2017 | 218 |
Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer | Cell | 2018 | 205 |
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics | Beneficial Microbes | 2014 | 193 |
Endocannabinoids--at the crossroads between the gut microbiota and host metabolism | Nature Reviews Endocrinology | 2016 | 191 |